[go: up one dir, main page]

PE20091092A1 - Compuestos heterociclicos como inhibidores de la via hedgehog - Google Patents

Compuestos heterociclicos como inhibidores de la via hedgehog

Info

Publication number
PE20091092A1
PE20091092A1 PE2008001563A PE2008001563A PE20091092A1 PE 20091092 A1 PE20091092 A1 PE 20091092A1 PE 2008001563 A PE2008001563 A PE 2008001563A PE 2008001563 A PE2008001563 A PE 2008001563A PE 20091092 A1 PE20091092 A1 PE 20091092A1
Authority
PE
Peru
Prior art keywords
methyl
inhibitors
carboxamide
pyridin
trifluoromethyl
Prior art date
Application number
PE2008001563A
Other languages
English (en)
Inventor
Benjamin Fauber
Alexander Hird
James Janetka
Daniel John Russell
Bin Yang
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PE20091092A1 publication Critical patent/PE20091092A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

REFERIDA A UN COMPUESTO DERIVADO HETEROCICLICO DE FORMULA (I), DONDE R1, R2 Y R3 SON H, HALOGENO O ALQUILO C1-C6; R4 ES HALOGENO, ALQUILO C1-C6 O HALOALQUILO C1-C6; W ES N, O, S, CR5, ENTRE OTROS; R5 ES H, ALCOXILO C1-C6, ALQUILO C1-C6, ENTRE OTROS; A ES N, CR6, NR6, N, O, S; R6 ES H, ALCOXILO C1-C6, AMINO, AMIDO, ENTRE OTROS; q Y p SON 0 O 1. SON COMPUESTOS PREFERIDOS: N-[4-CLORO-3-(1,5-DIMETIL-1H-IMIDAZOL-2-IL)FENIL]-2-METIL-6-(TRIFLUOROMETIL)PIRIDIN-3-CARBOXAMIDA, N-[4-CLORO-3-(1-METIL-1H-IMIDAZOL-2-IL)FENIL]-2-METIL-6-(TRIFLUOROMETIL)PIRIDIN-3-CARBOXAMIDA, N-[3-(5-AMINOPIRAZIN-2-IL)-4-CLOROFENIL]-2-METIL-6-(TRIFLUOROMETIL)PIRIDIN-3-CARBOXAMIDA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA VIA HEDGEHOG Y SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES PROLIFERATIVAS CELULARES
PE2008001563A 2007-09-05 2008-09-05 Compuestos heterociclicos como inhibidores de la via hedgehog PE20091092A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97010707P 2007-09-05 2007-09-05
US3666108P 2008-03-14 2008-03-14

Publications (1)

Publication Number Publication Date
PE20091092A1 true PE20091092A1 (es) 2009-08-27

Family

ID=39938463

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001563A PE20091092A1 (es) 2007-09-05 2008-09-05 Compuestos heterociclicos como inhibidores de la via hedgehog

Country Status (5)

Country Link
AR (1) AR068376A1 (es)
PE (1) PE20091092A1 (es)
TW (1) TW200916458A (es)
UY (1) UY31322A1 (es)
WO (1) WO2009030952A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1011247A2 (pt) * 2009-06-09 2016-06-21 California Capital Equity Llc derivados de isoquinolina, quinolina e quinazolina como inibidores de sinalização de hedgehog
PH12012501389A1 (en) 2010-01-07 2012-10-29 Selexagen Therapeutics Inc Hedgehog inhibitors
WO2011095807A1 (en) * 2010-02-07 2011-08-11 Astrazeneca Ab Combinations of mek and hh inhibitors
CN101993415B (zh) * 2010-09-15 2013-08-14 北京韩美药品有限公司 作为Hedgehog通路抑制剂的化合物以及包含该化合物的药物组合物及其应用
CN103570625A (zh) 2012-07-19 2014-02-12 南京英派药业有限公司 N-(3-杂芳基芳基)-4-芳基芳基甲酰胺和类似物作为Hedgehog通路抑制剂及其应用
US9242969B2 (en) 2013-03-14 2016-01-26 Novartis Ag Biaryl amide compounds as kinase inhibitors
UY36294A (es) 2014-09-12 2016-04-29 Novartis Ag Compuestos y composiciones como inhibidores de quinasa
AU2017329090B9 (en) 2016-09-19 2019-09-05 Novartis Ag Therapeutic combinations comprising a RAF inhibitor and a ERK inhibitor
US20190255042A1 (en) * 2016-11-04 2019-08-22 Impact Therapeutics, Inc Application of hedgehog pathway inhibitor in treating fibrosis diseases
KR20240032157A (ko) 2017-05-02 2024-03-08 노파르티스 아게 병용 요법
CN107281214A (zh) * 2017-06-06 2017-10-24 北京工业大学 氢分子液体/气体在制备抑制肿瘤干细胞药物中的应用
CN109369634B (zh) * 2018-12-19 2021-07-27 陕西国际商贸学院 具有抗肿瘤活性的2-甲氧基烟酰胺衍生物制备方法及用途
CN113795490A (zh) 2019-05-13 2021-12-14 诺华股份有限公司 N-(3-(2-(2-羟基乙氧基)-6-吗啉代吡啶-4-基)-4-甲基苯基)-2(三氟甲基)异烟酰胺的新结晶形式作为Raf抑制剂治疗癌症
US12018015B2 (en) 2021-06-18 2024-06-25 Aligos Therapeutics, Inc. Methods and compositions for targeting PD-L1
AU2022415440A1 (en) 2021-12-16 2024-05-30 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1474395E (pt) * 2002-02-12 2008-01-02 Smithkline Beecham Corp Derivados de nicotinamida úteis como inibidores de p38
DE60322869D1 (de) * 2002-04-22 2008-09-25 Univ Johns Hopkins Modulatoren von hedgehog signalpfaden, zusammensetzungen und verwandte verwendungen
WO2006078283A2 (en) * 2004-04-30 2006-07-27 Genentech, Inc. Quinoxaline inhibitors of hedgehog signalling
KR20130083488A (ko) * 2004-09-02 2013-07-22 제넨테크, 인크. 헤지호그 신호전달에 대한 피리딜 억제제
EP1807074B1 (en) * 2004-11-03 2013-10-23 Curis, Inc. Mediators of hedgehog signaling pathways, compositions and uses related thereto
WO2007042816A1 (en) * 2005-10-12 2007-04-19 Biolipox Ab Benzoxazoles useful in the treatment of inflammation
PE20080948A1 (es) * 2006-07-25 2008-09-10 Irm Llc Derivados de imidazol como moduladores de la senda de hedgehog

Also Published As

Publication number Publication date
WO2009030952A2 (en) 2009-03-12
TW200916458A (en) 2009-04-16
UY31322A1 (es) 2009-04-30
AR068376A1 (es) 2009-11-11
WO2009030952A3 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
PE20091092A1 (es) Compuestos heterociclicos como inhibidores de la via hedgehog
PE20090641A1 (es) Amidas heterociclicas
ECSP066886A (es) Compuestos y métodos para el tratamiento de dislipidemia
EA201290255A1 (ru) Способы и композиции для лечения рака
PE20090434A1 (es) Derivados de sulfonil amida como inhibidores de quinasas
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
PE20090694A1 (es) Compuestos moduladores de sirtuinas
ECSP067098A (es) Compuestos y metodos para el tratamiento de dislipidemia
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
PE20080906A1 (es) Derivados heteroarilo como inhibidores de citocina
EA200700099A1 (ru) Производные пиридина
PE20090423A1 (es) Compuestos moduladores de sirtuina
PE20060777A1 (es) Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
PE20091573A1 (es) Derivados heterociclicos de urea como inhibidores de adn girasa y/o topoisomerasa
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
PE20140471A1 (es) Moduladores de la via del complemento y usos de los mismos
CY1108908T1 (el) Ενωσεις κινολινονης - καρβοξαμιδης ως αγωνιστες υποδοχεων 5-ητ4
EA201000702A1 (ru) Некоторые производные 2-пиразинона и их применение в качестве ингибиторов нейтрофильной эластазы
PE20061150A1 (es) Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1)
PE20070136A1 (es) COMPUESTOS DERIVADOS DE N-(PIRIDIN-2-IL)-SULFONAMIDA COMO INHIBIDORES DE LA ENZIMA 11-beta-HIDROXIESTEROIDE DESHIDROGENASA HUMANA TIPO 1
PE20090884A1 (es) Compuestos de indol como activadores de glucoquinasa
PE20081404A1 (es) Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona y procesos para su preparacion
PE20081596A1 (es) Derivados fluorinados de deferiprona
PE20090606A1 (es) Nuevos inhibidores de catepsina c y uso
PE20090210A1 (es) Compuestos derivados de pirazolo pirimidina como inhibidores de jak quinasa

Legal Events

Date Code Title Description
FA Abandonment or withdrawal